Keep treatment focused only on the lip area
But mechanistic plausibility is not clinical proof
Network pharmacology and molecular docking suggested CA9 as a putative binding target of ATT-I which was confirmed by CETSA demonstrating increased thermal stability of CA9 upon ATT-I treatment
And so, uh, I think what, you know, Juan Carlos Belmonte and others have done was so brilliant in figuring out a way to kind of just, you know, pulse this these-these factors on and, uh, essentially wipe clear the-the program uh, the epigenetic program of the of the adult old cell and make it, you know, not-not a stem cell
But here, Ive adapted it with GLP-1 needs in mindespecially reduced appetite, digestive sensitivity, and the importance of protein
12, 2022 Eli Lilly & Co